2002 Fiscal Year Final Research Report Summary
New Therapeutic Approach for Congestive Heart Failure and Ischemia - reperfusion Injury Based on Cytokine Resistance
Project/Area Number |
13470144
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Circulatory organs internal medicine
|
Research Institution | NARA MEDICAL UNIVERSITY (2002) Kyoto University (2001) |
Principal Investigator |
SAITO Yoshihiko Nara Medical University, First Department of Internal Medicine, Professor, 医学部, 教授 (30250260)
|
Project Period (FY) |
2001 – 2002
|
Keywords | SOCS1 / SOCS3 / Cytokine Resistance / CT-1 / NF-_kB |
Research Abstract |
CIS (cytokine inducible SH2 protein), SOCS (suppressor of cytokine signaling) or SSI (STAT-induced STAT inhibitor) proteins are a family of cytokine-inducible negative regulators of cytokine signaling via Janus kinase (JAK)-signal transducers and activators of transcription (STAT) pathways. Given the evidence that JAK-STAT pathway plays a critical role in the cardiovascular system, the primary objective of this study is to assess the effects of CIS family on JAK-STAT signaling in the cardiovascular system in rats treated with cardiotrophin-1 (CT-1), an interleukin-6 family of cytokine. Intravenous injection of 20μg/kg body wt of CT- 1 induced transient, markedly increase in STAT3 activation in various tissues including heart and lung, and subsequent up-regulation of two members of CIS family, JAK binding protein (JAB)/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 in same tissues. Pretreatment with the same dose of CT-1 60 minutes before significantly attenuated the STAT3 activation induced by a second injection of CT-1. In rats pretreated with CT-1 either the induction of iNOS mRNA or hypotension by subsequent CT-1 injection was not observed. Furthermore, we demonstrate that pretreatment with CT-1 attenuated left ventricular function induced by non-fatal dose of LPS and LPS-induced cardiac dysfunction was blunted in mice over-expressing JAB/SOCS-1 specifically in heart.
|
Research Products
(9 results)
-
-
-
-
-
-
[Publications] E. Ogawa, Y. Saito, K. Kuwahara, M. Harada Y. Miyamoto, I. Hamanaka, N. Kajiyama, N. Takahashi, T. Izumi, R. Kawakami, I. Kishimoto, Y. Naruse, N. Mori , K. Nakao: "Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression."Cardiovasc. Res.. 53(1). 451-459 (2002)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Y. Mizuno, H. Yasue, M. Yoshimura, H. Fujii, N. Yamamoto, M. Nakayama, E. Harada T. Sakamoto, S. Nakamura, T. Ito, Y. Shimasaki, H. Ogawa, Y. Saito, K. Nakao: "Effects of Perindopril on Aldosterone Production in the Failing Human Heart"Am. J. Coll. Cardiol.. 89(10). 1197-1200 (2002)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Y. Li, I. Kishimoto, Y. Saito, M. Harada, K. Kuwahara, T. Izumi, N. Takahashi, R. Kawakami, K. Tanimoto, Y. Nakagawa, M. Nakanishi, Y. Adachi, DL. Garber s A. Fukamizu, K. Nakao: "Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart."Circulation. 106(13). 1722-1728 (2002)
Description
「研究成果報告書概要(欧文)」より
-